396 related articles for article (PubMed ID: 11413003)
21. The prion paradox: infection or polymerisation?
Biro JC
Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
[TBL] [Abstract][Full Text] [Related]
22. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
23. Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.
Brim S; Groschup MH; Kuczius T
PLoS One; 2016; 11(4):e0153931. PubMed ID: 27093554
[TBL] [Abstract][Full Text] [Related]
24. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
Weissmann C
FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
[TBL] [Abstract][Full Text] [Related]
25. Copper and the structural biology of the prion protein.
Viles JH; Klewpatinond M; Nadal RC
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1288-92. PubMed ID: 19021542
[TBL] [Abstract][Full Text] [Related]
26. Structuring the puzzle of prion propagation.
Eghiaian F
Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
[TBL] [Abstract][Full Text] [Related]
27. Prion protein: orchestrating neurotrophic activities.
Martins VR; Beraldo FH; Hajj GN; Lopes MH; Lee KS; Prado MA; Linden R
Curr Issues Mol Biol; 2010; 12(2):63-86. PubMed ID: 19767651
[TBL] [Abstract][Full Text] [Related]
28. Prion protein self-peptides modulate prion interactions and conversion.
Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
[TBL] [Abstract][Full Text] [Related]
29. [Prion protein and copper: a mysterious relationship].
Rachidi W; Riondel J; McMahon HM; Favier A
Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
[TBL] [Abstract][Full Text] [Related]
30. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
31. The expanded octarepeat domain selectively binds prions and disrupts homomeric prion protein interactions.
Leliveld SR; Dame RT; Wuite GJ; Stitz L; Korth C
J Biol Chem; 2006 Feb; 281(6):3268-75. PubMed ID: 16352600
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
Redecke L; Meyer-Klaucke W; Koker M; Clos J; Georgieva D; Genov N; Echner H; Kalbacher H; Perbandt M; Bredehorst R; Voelter W; Betzel C
J Biol Chem; 2005 Apr; 280(14):13987-92. PubMed ID: 15684434
[TBL] [Abstract][Full Text] [Related]
33. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
[TBL] [Abstract][Full Text] [Related]
34. Prion disease: A loss of antioxidant function?
Wong BS; Pan T; Liu T; Li R; Petersen RB; Jones IM; Gambetti P; Brown DR; Sy MS
Biochem Biophys Res Commun; 2000 Aug; 275(2):249-52. PubMed ID: 10964653
[TBL] [Abstract][Full Text] [Related]
35. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein.
Leach SP; Salman MD; Hamar D
Anim Health Res Rev; 2006; 7(1-2):97-105. PubMed ID: 17389057
[TBL] [Abstract][Full Text] [Related]
36. The prion protein and neuronal zinc homeostasis.
Watt NT; Hooper NM
Trends Biochem Sci; 2003 Aug; 28(8):406-10. PubMed ID: 12932728
[TBL] [Abstract][Full Text] [Related]
37. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
38. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
39. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
40. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
